Literature DB >> 11227643

Accuracy of MR imaging for staging prostate cancer: a meta-analysis to examine the effect of technologic change.

S S Sonnad1, C P Langlotz, J S Schwartz.   

Abstract

RATIONALE AND
OBJECTIVES: The purpose of this study was to summarize the accuracy of magnetic resonance (MR) imaging for staging prostate cancer and to determine the effect of high magnetic field strength, use of the endorectal coil, use of fast spin-echo (SE) imaging, and study size on staging accuracy.
MATERIALS AND METHODS: A literature search and review yielded 27 studies comparing MR imaging to a pathologic standard in patients with clinically limited prostate cancer. Subgroup analyses examined magnetic field strength, use of an endorectal coil, use of fast SE imaging, publication date, and study size.
RESULTS: A summary receiver operating characteristic curve for all studies had a maximum joint sensitivity and specificity of 74%. At a specificity of 80% on this curve, sensitivity was 69%. Subgroup analyses showed that fast SE imaging was statistically significantly more accurate than conventional SE techniques (P < .001). Unexpectedly, studies employing higher magnetic field strength and those employing an endorectal coil were less accurate.
CONCLUSION: Seemingly small technologic advances may influence test accuracy. Early and small studies, however, may overstate accuracy because of publication bias, bias in small samples, or earlier studies being performed by the experts who developed the technology itself.

Entities:  

Mesh:

Year:  2001        PMID: 11227643     DOI: 10.1016/s1076-6332(01)90095-9

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  17 in total

1.  Prediction of prostate cancer extracapsular extension with high spatial resolution dynamic contrast-enhanced 3-T MRI.

Authors:  B Nicolas Bloch; Elizabeth M Genega; Daniel N Costa; Ivan Pedrosa; Martin P Smith; Herbert Y Kressel; Long Ngo; Martin G Sanda; William C Dewolf; Neil M Rofsky
Journal:  Eur Radiol       Date:  2012-06-03       Impact factor: 5.315

Review 2.  Diffusion weighted imaging in prostate cancer.

Authors:  Cher Heng Tan; Jihong Wang; Vikas Kundra
Journal:  Eur Radiol       Date:  2010-10-09       Impact factor: 5.315

Review 3.  Is it time to consider a role for MRI before prostate biopsy?

Authors:  Hashim U Ahmed; Alex Kirkham; Manit Arya; Rowland Illing; Alex Freeman; Clare Allen; Mark Emberton
Journal:  Nat Rev Clin Oncol       Date:  2009-04       Impact factor: 66.675

Review 4.  Variation of a test's sensitivity and specificity with disease prevalence.

Authors:  Mariska M G Leeflang; Anne W S Rutjes; Johannes B Reitsma; Lotty Hooft; Patrick M M Bossuyt
Journal:  CMAJ       Date:  2013-06-24       Impact factor: 8.262

Review 5.  [Imaging modalities for primary diagnosis and staging of prostate cancer].

Authors:  U G Mueller-Lisse; K Miller
Journal:  Urologe A       Date:  2010-02       Impact factor: 0.639

6.  Diffusion-weighted MRI in the detection of prostate cancer: meta-analysis.

Authors:  Cher Heng Tan; Wei Wei; Valen Johnson; Vikas Kundra
Journal:  AJR Am J Roentgenol       Date:  2012-10       Impact factor: 3.959

7.  Dynamic contrast-enhanced MRI for the detection of prostate cancer: meta-analysis.

Authors:  Cher Heng Tan; Brian Paul Hobbs; Wei Wei; Vikas Kundra
Journal:  AJR Am J Roentgenol       Date:  2015-04       Impact factor: 3.959

Review 8.  Contemporary issues in the diagnosis of prostate cancer for the radiologist.

Authors:  Richard Clements
Journal:  Eur Radiol       Date:  2006-04-01       Impact factor: 5.315

9.  Modalities for imaging of prostate cancer.

Authors:  A H Hou; D Swanson; A B Barqawi
Journal:  Adv Urol       Date:  2010-03-17

Review 10.  Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer.

Authors:  John Kurhanewicz; Mark G Swanson; Sarah J Nelson; Daniel B Vigneron
Journal:  J Magn Reson Imaging       Date:  2002-10       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.